SUTAB (Magnesium Sulfate; Potassium Chloride; Sodium Sulfate) Patent Expiration, LOE Window & CMS Spending

SUTAB (Magnesium Sulfate; Potassium Chloride; Sodium Sulfate) by Azurity: FDA Orange Book core substance LOE 2037-08-04, 1 AB generics, $0 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorAzurity
FDA Application & PathwayN213135 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE Date2037-08-04
Last Listed Patent or Exclusivity Date2037-08-04
Orange Book Patents (*PED Extensions)4 patents (0 *PED)
Active AB-Rated Generic Competitors1
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel